Cardiac Risk for Vitrectomy
Vitrectomy is classified as a low-risk ophthalmic procedure with a cardiac risk of less than 1% for major adverse cardiac events (cardiac death or nonfatal myocardial infarction), and therefore does not routinely require preoperative cardiac risk assessment or testing in most patients. 1
Risk Stratification
According to ACC/AHA perioperative guidelines, ophthalmic procedures including vitrectomy fall into the low-risk surgical category with reported cardiac risk generally less than 1%. 1 This classification places vitrectomy alongside other procedures like cataract surgery, endoscopic procedures, and superficial surgeries—all of which do not generally require further preoperative cardiac testing.
When to Perform Cardiac Assessment
The 2024 AHA/ACC guidelines and Canadian Cardiovascular Society guidelines provide clear direction on who needs preoperative cardiac evaluation: 2, 3
- Emergency surgery: Proceed without delay for cardiac assessment
- Urgent/semi-urgent surgery: Only assess if there is suspected severe obstructive intracardiac abnormality, severe pulmonary hypertension, or unstable cardiovascular condition (unstable angina, acute stroke)
- Elective surgery in patients ≥45 years or 18-44 years with known significant cardiovascular disease: These patients have the most to gain from preoperative cardiac risk evaluation
For vitrectomy specifically, since it is low-risk and typically performed under local monitored anesthesia care, most patients can proceed directly to surgery without cardiac testing, even elderly patients with stable cardiac conditions.
Anesthetic Considerations and Cardiac Safety
The ophthalmology guidelines consistently note that vitrectomy is typically performed under local monitored anesthesia care, which significantly reduces cardiac stress compared to general anesthesia. 4, 5, 6, 5, 6, 5 General anesthesia is reserved for anxious or claustrophobic patients.
Important Cardiac Precautions
Nitrous oxide must be avoided during the last 10 minutes of air-fluid exchange when general anesthesia is used, as it can result in unpredictable gas fill postoperatively. 4
Rare but Serious Cardiac Complications
While vitrectomy is low-risk, there are documented rare cardiac events:
Venous Air Embolism
The most serious potential cardiac complication is venous air embolism during air-fluid exchange, which can cause cardiac arrest. 7, 8 This is exceedingly rare but potentially life-threatening. Signs include:
- Sudden decrease in end-tidal CO2
- Drop in oxygen saturation
- Hypotension
- Rapid progression to cardiac arrest
Management: Immediate termination of air infusion; consider extracorporeal life support in fatal cases. 7
Acute Pulmonary Edema
Two case reports document postoperative pulmonary edema in patients with pre-existing ischemic heart disease and left ventricular diastolic dysfunction following vitrectomy. 9 This occurred despite vitrectomy being a procedure with minimal hemodynamic change and surgical stimulation.
High-Risk Patient Management
For patients with ischemic heart disease and LV diastolic dysfunction, consider:
- Intraoperative transthoracic or transesophageal echocardiogram
- Continuous blood pressure monitoring with arterial catheter
- Enhanced vigilance in the post-anesthetic care unit 9
Antiplatelet/Anticoagulant Medications
Continuation of antiplatelet or anticoagulant agents does not significantly increase the risk of severe intraoperative bleeding during vitreoretinal surgery. 10 These medications should generally be continued, as the cardiac risk of stopping them likely exceeds any bleeding risk during this low-risk procedure.
Clinical Algorithm
- Assess surgical urgency: Vitrectomy for conditions like retinal detachment may be urgent; macular hole/ERM surgery is elective
- Screen for unstable cardiac conditions: unstable angina, recent MI, decompensated heart failure, severe arrhythmias
- If unstable cardiac condition present: Stabilize before proceeding
- If stable or no cardiac disease: Proceed directly to surgery without additional cardiac testing
- For patients with known ischemic heart disease + diastolic dysfunction: Consider enhanced intraoperative monitoring
- Continue cardiac medications including antiplatelet/anticoagulant agents perioperatively
Common Pitfalls to Avoid
- Over-testing: Do not order routine stress tests or echocardiograms for this low-risk procedure in stable patients
- Unnecessary delays: Delaying surgery for cardiac clearance in stable patients provides no benefit and may worsen visual outcomes
- Stopping anticoagulation: The bleeding risk during vitrectomy does not justify stopping antiplatelet or anticoagulant therapy in most cases
The key principle is that vitrectomy's low cardiac risk profile means standard cardiac evaluation guidelines for noncardiac surgery apply, with most patients proceeding directly to surgery without additional cardiac workup beyond routine clinical assessment.